AnalystsMatthew KellerMatthew Keller's Stock Forecasts
AnalystsMatthew Keller
Sectors:
Industries:
Analyst Ranking
Bottom 6%
#5224 out of 5511 analysts
Average Return
-19.72%
Win Rate
16%3 out of 19
Risk vs Reward
Poor
Good
Matthew Keller Analyst Color
Get additional color on Matthew Keller's coverage of popular stocks
Matthew Keller's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gri Bio IncGRI | 1 | Buy | $10.00 | +449.45% | Reiterates | 6 days ago |
Kyntra Bio IncKYNB | 3 | Buy | $43.00 | +453.41% | Reiterates | 15 days ago |
Phio Pharmaceuticals CorpPHIO | 3 | Buy | $14.00 | +1,272.55% | Reiterates | 21 days ago |
Galectin Therapeutics IncGALT | 3 | Buy | $11.00 | +194.91% | Reiterates | 3 months ago |
Seres Therapeutics IncMCRB | 1 | Buy | $12.00 | +160.87% | Initiates Coverage On | 3 months ago |
60 Degrees Pharmaceuticals IncSXTP | 3 | Hold | N/A | N/A | Downgrades | 4 months ago |
Inflarx NvIFRX | 3 | Buy | $8.00 | +296.04% | Maintains | 4 months ago |
Acurx Pharmaceuticals IncACXP | 2 | Buy | $31.00 | +2,187.82% | Reiterates | a year ago |
Gyre Therapeutics IncGYRE | 1 | Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.